Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein (ISSP-001)
This study has been completed.
Study NCT00529698   Information provided by Istituto Superiore di Sanità

First Received on September 13, 2007.   Last Updated on February 28, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Sponsors listed in this trial